Author

Kasper Almholt

Global Drug Discovery, Novo Nordisk A/SORCID 0000-0002-9250-514XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Andreas HaldiD· 1 shared Birgitte Martine ViuffiD· 1 shared Chris J. WestoniD· 1 shared Elisabeth Douglas GalsgaardiD· 1 shared Ellie NorthalliD· 1 shared Emma L. ShepherdiD· 1 shared Franziska ZoseliD· 1 shared Helle Demuth· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Andreas HaldORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PathologyeLifePeer-reviewedJul 8, 2024

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

Paul Horn, Jenny Norlin, Kasper Almholt…·Philip Noel Newsome

This study evaluates Gremlin-1 as a therapeutic target in MASH fibrosis, finding it upregulated but not amenable to targeting due to its restricted expression and lack of effect on fibrogenesis.

7 citations

rathuman

𝕏 PostBluesky